HIGHLIGHTS
- who: Bladder Cancer et al. from the Department of Urology, Zhuzhou Central Hospital, Zhuzhou, China Division of Urology, Department of Surgery, The University of Hongkong-Shenzhen Hosipital, Shenzhen, China have published the article: Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer, in the Journal: Oxidative Medicine and Cellular Longevity of 13/09/2022
- what: The authors aimed to propose the targeted macrophage control based on MPOP as a treatment method for BCa immunotherapy.
- how: To explore the mechanism of phagocytosis regulators in tumor development the authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.